Papers

3

Total Citations

16

H-Index

2

About

Farhoud Faraji is a clinician-scientist whose work is reshaping the surgical management of head and neck cancers, with a particular focus on transoral robotic surgery (TORS) and its impact on patient outcomes. His research spans the oncologic efficacy of minimally invasive techniques, from the hypopharynx to the oropharynx, where he has provided critical evidence that robotic surgery may improve survival for T1 and T2 hypopharyngeal tumors—a finding drawn from a national NCDB cohort study. Dr. Faraji has also advanced the understanding of HPV-positive oropharyngeal carcinoma, demonstrating that TORS yields favorable long-term outcomes even within the Veterans Affairs system, a setting distinct from high-volume academic centers. His work on positive surgical margins, analyzing national trends in oral cavity and oropharyngeal malignancies, identifies persistent challenges and predictors of incomplete resection. With over 16 citations across his most influential papers, Dr. Faraji’s contributions are guiding surgical decision-making and highlighting disparities in care. His achievements include pioneering research that bridges surgical innovation with real-world, population-level data, making him a rising voice in head and neck oncology.

Research Focus

Key Achievements

2
H-Index
3
Papers
16
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Robotic surgery may improve overall survival for T1 and T2 tumors of the hypopharynx: An NCDB cohort study
10 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: University of California San Diego, University of San Diego, UC San Diego Health System

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago